top of page

Pharmac - Supply Issue: podophyllotoxin (Condyline) solution 0.5%

ree


We are writing to inform you of that there has been a delay with a recent shipment of Condyline solution 0.5%

 

Key messages:


  • AFT notified Pharmac that it could not release a recent shipment of Condyline due to significant temperature excursions in transit.

  • The next production of Condyline solution 0.5% is not until December 2025.

  • There is an anticipated out-of-stock period from October 2025 to January 2026.

  • AFT has secured supply of an alternative Condyline product from the French market which will be available late October, and we therefore expect a potential supply gap.

  • This is the same product produced at the same manufacturer as the New Zealand Condyline but is entirely French labelled (with no English labelling).

  • To make the French pack suitable the main panel will be over labelled with English language and an English language Consumer Medicine Information Leaflet will be provided.

  • The alternative product will be listed on the Pharmaceutical schedule from 1 October 2025.

  • This is not a Medsafe approved medicine and will be supplied under Section 29 of the Medicines Act.

  • For more information, please see Condyline on Pharmac website

 

Questions: 

If you have any queries, please contact us at enquiry@pharmac.govt.nz

 

Please share this information:

Please share this information with your colleagues and within your networks.

 


Ngā mihi,

 

Anna I Senior Advisor Implementation

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz

 


bottom of page